Search Results
You are looking at 1 - 1 of 1 items for
- Author: Chi-Sheng Hung x
- Refine by access: All content x
National Taiwan University Hospital Primary Aldosteronism Center, Taipei, Taiwan
Search for other papers by Cheng-Hsuan Tsai in
Google Scholar
PubMed
Search for other papers by Zheng-Wei Chen in
Google Scholar
PubMed
Search for other papers by Bo-Ching Lee in
Google Scholar
PubMed
Search for other papers by Che-Wei Liao in
Google Scholar
PubMed
Search for other papers by Yi-Yao Chang in
Google Scholar
PubMed
Search for other papers by Yan-Rou Tsai in
Google Scholar
PubMed
Search for other papers by Chia-Hung Chou in
Google Scholar
PubMed
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
Search for other papers by Vin-Cent Wu in
Google Scholar
PubMed
National Taiwan University Hospital Primary Aldosteronism Center, Taipei, Taiwan
Search for other papers by Chi-Sheng Hung in
Google Scholar
PubMed
National Taiwan University Hospital Primary Aldosteronism Center, Taipei, Taiwan
Search for other papers by Yen-Hung Lin in
Google Scholar
PubMed
Aldosterone is a mineralocorticoid hormone involved in controlling electrolyte balance, blood pressure, and cellular signaling. It plays a pivotal role in cardiovascular and metabolic physiology. Excess aldosterone activates mineralocorticoid receptors, leading to subsequent inflammatory responses, increased oxidative stress, and tissue remodeling. Various mechanisms have been reported to link aldosterone with cardiovascular and metabolic diseases. However, mitochondria, responsible for energy generation through oxidative phosphorylation, have received less attention regarding their potential role in aldosterone-related pathogenesis. Excess aldosterone leads to mitochondrial dysfunction, and this may play a role in the development of cardiovascular and metabolic diseases. Aldosterone has the potential to affect mitochondrial structure, function, and dynamic processes, such as mitochondrial fusion and fission. In addition, aldosterone has been associated with the suppression of mitochondrial DNA, mitochondria-specific proteins, and ATP production in the myocardium through mineralocorticoid receptor, nicotinamide adenine dinucleotide phosphate oxidase, and reactive oxygen species pathways. In this review, we explore the mechanisms underlying aldosterone-induced cardiovascular and metabolic mitochondrial dysfunction, including mineralocorticoid receptor activation and subsequent inflammatory responses, as well as increased oxidative stress. Furthermore, we review potential therapeutic targets aimed at restoring mitochondrial function in the context of aldosterone-associated pathologies. Understanding these mechanisms is vital, as it offers insights into novel therapeutic strategies to mitigate the impact of aldosterone-induced mitochondrial dysfunction, thereby potentially improving the outcomes of individuals affected by cardiovascular and metabolic disorders.
